Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon. (Q51989413)
Jump to navigation
Jump to search
scientific article published in September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon. |
scientific article published in September 2005 |
Statements
Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon. (English)
1 reference
1 reference
Jacques Banchereau
1 reference
Madhav Dhodapkar
1 reference
John Connolly
1 reference
Jennifer P Finholt
1 reference
Eynav Klechevsky
1 reference
Jean-Philippe Blanck
1 reference
Dennis A Johnston
1 reference
A Karolina Palucka
1 reference
Joseph Fay
1 reference
1 September 2005
1 reference
28
1 reference
5
1 reference
505-516
1 reference